Skip to content

The Microbiome and Resilience to Sleep and Circadian Disruption

The Microbiome and Responsiveness to Stress: Countermeasure Strategies for Improving Resilience to Sleep and Circadian Disruption (Experiments 1 & 2)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03747367
Enrollment
55
Registered
2018-11-20
Start date
2015-10-21
Completion date
2020-03-16
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Dysregulation, Sleep Deprivation, Stress

Keywords

Microbiome, Stress, Sleep, Circadian

Brief summary

This study is about how sleep loss and being awake at night impacts the ability to think, changes molecules in the blood, and alters the bacteria that live in the gut that typically help keep people healthy. This work will have important implications for the development of treatments and countermeasures for people who do not sleep enough and need to be active at different times of the day and night (e.g., emergency workers and military personnel).

Detailed description

Experiment 1: Consistency of microbiota-gut-brain axis responses Prior to the start of this study, there are screening procedures to ensure participants meet the criteria for the study. At the first consent screening appointment, participants will learn more about the study, answer questionnaires, and complete a psychological interview. At the second medical screening appointment, participants will have a physical exam, blood work, drug screen, pregnancy test, electrocardiogram (a measurement of heart activity), and a resting metabolic rate assessment (a measurement of how much energy the body uses at rest). Participants will also meet with a nutritionist to discuss their food preferences for the study. Although participants are not financially compensated for the screening procedures, the expense of the screening tests is covered and copies are provided to the participant upon request. All of the results of the screening procedures are confidential and will only be used by the study staff to determine eligibility for the study. Following the screening procedures, participants will complete two laboratory visits, both visits preceded by two weeks of home activity monitoring. During the home monitoring, participants wear a special watch that records activity levels. Participants also keep a sleep/wake log and use a website to log their daily sleep/wake times (if participants cannot access this website, they can call into an answering machine to inform investigators when they go to bed and wake up each day). The investigators will provide participants with a pre-study diet prepared by study dieticians for participants to eat for the three days prior to the laboratory visit. During the two weeks between the first and second laboratory visit participants will continue to wear the special watch, keep a sleep/wake log, and use a website to log their daily sleep/wake times (or call them into the answering machine). Participants will again be given a pre-study diet for the three days prior to their second visit. During the laboratory visits, participants will live in the Sleep and Chronobiology Lab at the University of Colorado at Boulder for 3.7 days on two different occasions. The day before the inpatient visit begins, participants will spend the night in the laboratory, sleeping their normal 8 hours. This will be used as a pre-study screening for problems with sleep. In the morning participants will complete some pre-study tests and samples which will take approximately 60 minutes. Participants will then be permitted to leave the laboratory and in the evening they will return to begin the study. During the study participants sleep schedule will be changed to simulate the sleep loss that emergency workers in medical and military situations experience. Participants will be given an initial 3 hour sleep opportunity and then kept awake overnight. Throughout the study participants will be given a 3 hour sleep opportunity for every 24 hours of the laboratory visit. While participants are awake, they will be asked to perform a number of computer tasks, including a driving simulator. Blood and saliva samples will be taken to test for circadian and metabolic markers. Participants will also be asked to collect samples of the bacteria that live in their gastrointestinal tract from used bathroom tissue after they use the bathroom in the study. Finally, investigators will test how the heart and nervous system respond to stress by having participants place their hand in an ice water bath. At the end of the laboratory visit participants will be given an 11 hour sleep opportunity to recover from their sleep loss. After 3 more days of recovery sleep and another 2 weeks of home monitoring (identical to the first two weeks of the study), these procedures will be repeated in a second laboratory visit. Experiment 2: Pre-biotic Methods for experiment 2 are exactly the same as experiment 1 with the following addition: During the two weeks prior to laboratory visits, half of the study participants will be randomized (e.g., flip of a coin) to receive the prebiotic combination of polydextrose (PDX) and galacto-oligosaccharides (GOS) daily for 2 weeks and then tested in the first in-laboratory visit. These participants will then receive a maltodextrin placebo (a starch-derived food additive commonly used as a filling agent in a range of commercial foods and beverages) the two weeks prior to the second in-laboratory visit. The other half of participants will first receive maltodextrin and then the prebiotic diet. Investigators will provide participants the prebiotics and maltodextrin powders to be mixed in water and consumed each morning. The order in which participants receive the prebiotic diet will be maintained by the Clinical and Translational Research Center pharmacist. Neither the investigators nor participants will know what is in the powder provided. Experiment 3: Pre-biotic in Early Morning Shift Workers Prior to the start of this study, there are screening procedures to ensure participants meet the criteria for the study. At the first consent screening appointment, participants will learn more about the study and answer questionnaires. At the second medical screening appointment, participants will have a physical exam, blood work, drug screen, pregnancy test, electrocardiogram (a measurement of heart activity). Participants will also meet with a nutritionist to discuss their food preferences for the study. Although participants are not financially compensated for the screening procedures, the expense of the screening tests is covered and copies are provided to the participant upon request. All of the results of the screening procedures are confidential and will only be used by the study staff to determine eligibility for the study. Following screening procedures, participants who are early morning shift workers (working at least 2 consecutive early morning (4-7am) work shifts), will complete an approximate 5 week study with the majority of research procedures being done at home. During the two weeks prior to laboratory visits, half of the study participants will be randomized (e.g., flip of a coin) to receive the prebiotic combination of polydextrose (PDX) and galacto-oligosaccharides (GOS) daily for 2 weeks, then will come into the laboratory for a brief visit to have a fasting blood draw taken. After a minimum one week washout period with no data collection, these participants will then receive a maltodextrin placebo (a starch-derived food additive commonly used as a filling agent in a range of commercial foods and beverages) the two weeks prior to the next in-laboratory visit where another fasting blood draw will be taken. The other half of participants will first receive maltodextrin and then the prebiotic diet. Investigators will provide participants the prebiotics and maltodextrin powders to be mixed in water and consumed each morning. The order in which participants receive the prebiotic diet will be maintained by a PhD collaborator not involved with administration of the study protocol. Neither the investigators nor participants will know what is in the powder provided. During both two week data collection periods, participants will be outfitted with a continuous glucose monitor to be worn on the back of the arm, given an actiwatch to monitor activity and light levels to be worn on the wrist, and will be instructed to collect fecal samples at home and freeze these samples immediately. Additionally, for three days at home during both data collection periods, participants will be given an outpatient diet designed to meet caloric needs to control for food intake during fecal sampling periods. Finally, participants will be asked to fill out questionnaires related to their mood and sleep. Including screening appointments, there are a total of 8 visits required for this experiment. Experiment 4: Pre-biotic in Individuals Receiving Insufficient Sleep Similar to experiment 3, the majority of research procedures will be done at home following screening procedures. At the first consent screening appointment, participants will learn more about the study and answer questionnaires. Following screening procedures, participants who regularly receive less than 6.5 hours time in bed trying to sleep, will complete a 5 week study with the majority of research procedures being done at home. During the two weeks prior to laboratory visits, half of the study participants will be randomized (e.g., flip of a coin) to receive the prebiotic combination of polydextrose (PDX) and galacto-oligosaccharides (GOS) daily for 2 weeks, then will come into the laboratory for a brief visit to have a fasting blood draw taken. After a one week washout period with no data collection, these participants will then receive a maltodextrin placebo (a starch-derived food additive commonly used as a filling agent in a range of commercial foods and beverages) the two weeks prior to the next in-laboratory visit where another fasting blood draw will be taken. The other half of participants will first receive maltodextrin and then the prebiotic diet. Investigators will provide participants the prebiotics and maltodextrin powders to be mixed in water and consumed each morning. The order in which participants receive the prebiotic diet will be maintained by a PhD collaborator not involved with administration of the study protocol. Neither the investigators nor participants will know what is in the powder provided. During both two week data collection periods, participants will be outfitted with a continuous glucose monitor to be worn on the back of the arm, given an actiwatch to monitor activity and light levels to be worn on the wrist, and will be instructed to collect fecal samples at home and freeze these samples immediately. Additionally, for three days at home during both data collection periods, participants will be asked to consume food similar to their normal food intake for 3 days and record this intake to control for food intake during fecal sampling periods. Finally, participants will be asked to fill out questionnaires related to their mood and sleep. Including screening appointments, there are a total of 5 visits required for this experiment.

Interventions

BEHAVIORALInsufficient Sleep
DIETARY_SUPPLEMENTPrebiotic

Polydextrose and Galacto-oligosaccharide prebiotic supplement

DIETARY_SUPPLEMENTPlacebo

Maltodextrin (placebo) supplement

Sponsors

University of Colorado, Boulder
Lead SponsorOTHER
University of California, San Diego
CollaboratorOTHER
Office of Naval Research (ONR)
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

Experiment 1 - none Experiment 2 - double-blind Experiment 3 - double-blind Experiment 4 - double-blind

Intervention model description

Experiment 1 - Single group, repeated assessment Experiment 2 - Double-blind, randomized, cross-over design Experiment 3 - Double-blind, randomized, cross-over design Experiment 4 - Double-blind, randomized, cross-over design

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Currently residing at Denver altitude or higher

Exclusion criteria

* Current major medical disorder Experiment 1 and 2, ages 18-35. Experiment 3 and 4, 18-45. Experiment 3 only: Early Morning Shift Workers Experiment 4 only: Individuals Receiving Less than 6.5 hours of Sleep At Night

Design outcomes

Primary

MeasureTime frameDescription
Change in fecal microbiomeDaily fecal samples while living in laboratory (3 samples per visit, 2 laboratory visits as part of a 39 day protocol). Experiment 3 and 4: Fecal samples taken at home, one from each condition (prebiotic and placebo)Fecal "beta diversity" (unit=weighted UniFrac)
Change in fecal metabolomeDaily fecal samples while living in laboratory (3 samples per visit, 2 laboratory visits as part of a 39 day protocol). Experiment 3 and 4: Fecal samples taken at home, one from each condition (prebiotic and placebo)Fecal small molecules (Mass spect metabolite abundance)

Secondary

MeasureTime frameDescription
Visual Search PerformanceAssessed every 3 hours daily while living in the laboratory (17 times per visit, 2 laboratory visits as part of a 39 day protocol). N/A for experiment 3 and 4.Cognitive Throughput (items/minute)
Maintenance of wakefulness testAssessed every 3 hours daily while living in the laboratory (17 times per visit, 2 laboratory visits as part of a 39 day protocol). N/A for experiment 3 and 4.Average latency to falling asleep (minutes)
Karolinska Sleepiness ScaleAssessed every 3 hours daily while living in the laboratory (17 times per visit, 2 laboratory visits as part of a 39 day protocol). N/A for Experiment 3 and 4.Single question likert scale: Total score reported with a range of 1-9; min score=1\[very alert\], maximum score=9\[very sleepy, great effort to keep awake, fighting sleep\]. A higher score representing higher sleepiness. A lower score represents less sleepiness and a better outcome.
Changes in plasma metabolomeAssessed ~every 6 hours while living in the laboratory (10 times per visit, 2 laboratory visits as part of a 39 day protocol). Experiment 3 and 4: Fasted blood samples taken once from each condition (prebiotic and placebo)Plasma small molecules (Mass spect metabolite abundance)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKenneth Wright, PhD

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026